Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-01-07
2009-11-10
McIntosh, III, Traviss C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S023000, C514S042000, C536S022100, C536S029100, C536S029130
Reexamination Certificate
active
07615536
ABSTRACT:
The invention relates to the compound of the formula (A) and also to its physiologically acceptable salts. The compound is suitable as, for example, a hypolipidemic
REFERENCES:
patent: 6221897 (2001-04-01), Frick et al.
patent: 6277831 (2001-08-01), Frick et al.
patent: 0153913 (1985-09-01), None
patent: 0864582 (1998-09-01), None
patent: WO 00/61568 (2000-10-01), None
Frick Wendelin
Glombik Heiner
Heuer Hubert
Schaefer Hans-Ludwig
Theis Stefan
Kurys Barbara E.
McIntosh, III Traviss C
Sanofi-Aventis Deutschland GmbH
LandOfFree
1,4-benzothiazepine 1,1-dioxide derivative, process for its... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,4-benzothiazepine 1,1-dioxide derivative, process for its..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-benzothiazepine 1,1-dioxide derivative, process for its... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4084233